References
Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44:S6–9.
Wursthorn K, Buggisch P, Lutgehetmann M, et al. Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV. Antivir. Ther. 2006;11:647–52.
Soriano V, Puoti M, Peters M, et al. Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV–Hepatitis B Virus International Panel. AIDS. 2008;22:1399–410.
Konopnicki D, Mocroft A, de Wit S, et al. Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDAcohort. AIDS. 2005;19:593–601.
Martín-Carbonero L, Teixeira T, Soriano V, et al. Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues. AIDS. 2011;25:73–9.
Gozlan J, Lacombe K, Gault E, et al. Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV. J Hepatol. 2009;50:432–4.
Wölfel T, Schirmacher P, Schlaak J, et al. Sustained elimination of hepatitis B virus from serum induced in a patient with chronic hepatitis B and advanced human immunodeficiency virus infection. Clin Invest. 1994;72:1030–6.
Núñez M, Ramos B, Díaz-Pollán B, et al. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retroviruses. 2006;22:842–8.
Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188:2199–204.
Psevdos G Jr, Kim JH, Suh JS, et al. Predictors of loss of hepatitis B surface antigen in HIV-infected patients. World J Gastroenterol. 2010;16:1093–6.
Brunetto MR. A new role for an old marker, HBsAg. J Hepatol. 2010;52:475–7.
Marcellin P, Boyer N, Colin J, et al. Recombinant α interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. Gut. 1993;34:S106.
Di Martino V, Thevenot T, Colin J, et al. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology. 2002;123:1812–22.
Rockstroh JK, Bhagani S, Benhamou Y, et al. EACS Executive Committee European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med. 2008;9:82–8.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rossetti, B., Bianco, C. & De Luca, A. Hepatitis B virus surface antigen seroconversion after pegylated interferon-alpha treatment in an HIV-infected individual with chronic hepatitis B. Infection 40, 347–349 (2012). https://doi.org/10.1007/s15010-011-0198-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-011-0198-1